COVID-19
Conditions
Brief summary
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if echocardiography - both conventional and advanced - can be used to predict which patients will develop acute respiratory distress syndrome (ARDS) or other short-term acute complications, especially focusing on cardiovascular outcomes. In addition, using a novel technique of lung ultrasound (LUS), The investigators aim to analyze specific LUS-findings, and associate them with short-term prognosis and development of ARDS and long-term cardiovascular morbidity and mortality. In all patients included, The investigators aim to examine long-term complications at timepoints: 2, 5 and 10 years of follow-up and examine if echocardiography - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a laboratory confirmed diagnosis of COVID-19 \> 18 years of age.
Exclusion criteria
* Persons not able to cooperate * Persons unable to understand and sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis | 2.5 months |
| In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis | 2.5 months |
| Incident ARDS (Adult Respiratory Distress Syndrome) and intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis | 2.5 months |
Secondary
| Measure | Time frame |
|---|---|
| Incident stroke after hospital admission with a confirmed COVID-19 diagnosis at follow-up | 2.5 months to 10 years |
| Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis | 2.5 months |
| Incident myocardial infarction after hospital admission with a confirmed COVID-19 diagnosis at follow-up | 2.5 months to 10 years |
| Incident heart failure after hospital admission with a confirmed COVID-19 diagnosis at follow-up | 2.5 months to 10 years |
| Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis | 2.5 months |
| Death from any cause after hospital admission with a confirmed COVID-19 diagnosis at follow-up | 2.5 months to 10 years |
Countries
Denmark